To reliably examine the enzymatic activity of LRRK2 and GCase in peripheral immune cells and to identify related inflammatory biomarker candidates for PD, it is important to standardize protocols to ensure biomarker specimen stability and reproducibility across institutes. Here, LRRK2 is linked to Parkinson disease.